Could a diaphragm pacemaker help failing hearts?

NCT ID NCT06552637

First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests a device that stimulates the diaphragm in time with the heartbeat to help people with heart failure. Researchers will see if it improves heart function, exercise ability, and quality of life. About 270 participants will receive the device plus standard care, or standard care alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Synchronized Diaphragmatic Stimulation device (VisONE System)
What this could lead to
If it works, this could offer a new treatment option for people with heart failure, potentially improving heart function, exercise ability, and quality of life.
What could go wrong
This is an early-stage trial with 270 participants, so results may not apply to everyone. The device requires surgery and carries risks like infection, breathing problems, or heart complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Saint Francis Hospital

    RECRUITING

    Tulsa, Oklahoma, 74136, United States

  • Tbilisi Heart and Vascular Clinic

    RECRUITING

    Tbilisi, 0159, Georgia

  • University of Pennsylvania

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.